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Summary: The influence of the high-molecular-mass sample matrix in the direct enzymatic measurement of
glucose in haemolysate was investigated by a comparison study using ultrafiltered haemolysate for reference.
Haemolysate was obtained by 1 : 21 dilution of whole blood with a solution of digitonin and maleinimide. It
was shown that at low protein concentration glucose distributes in a 1 : 1 ratio during ultrafiltration. With a
hexokinase/glucose-6-phosphate dehydrogenase procedure excellent agreement was found between values
measured in haemolysate (y) and ultrafiltrates (x), when incubation was performed at 25 °C (a = 0.047
mmol/1; b = 0.99; r = 0.999, n = 37); at 37 °C, however, the same procedure resulted in a non-tolerable
systematic deviation in the direct analysis of haemolysate (a = —0.426 mmol/1; b = 1.00, r = 0.997, n = 37).
The precision of measurements in haemolysate and ultrafiltrate was similar (CV 1.0 — 1.2%). Since stable
reference material with an appropriate matrix is not available, it is important to evaluate haemolysate
procedures carefully by comparison studies with patient samples. For reduction of experimental error in such
studies we recommend the use of ultrafiltered haemolysate, since this can be analysed side by side with
haemolysate in the same run.
Introduction
The hexokinase/glucose-6-phosphate dehydrogenase1) glucose (2) the performance of the hexokinase method
principle is the basis for both reference and routine may be compromised by the high-molecular-mass
measurement of glucose concentration in body fluids, compounds of the sample matrix, e. g., haemoglobin,
In the generally accepted reference measurement pro- erythrocyte phosphogluconate dehydrogenase1) and
cedure, protein-free supernatant is used for the anal- glucosephosphate isomerase1) (3). Although it has
ysis of serum (1). Field methods preferably omit de- been shown that good agreement between glucose
proteinization for reasons of simplification, but this values obtained from haemolysate and protein-free
may be counterbalanced by a loss of accuracy. Es- supernatant is achievable (3 — 4), this has to be con-
pecially in the direct analysis of haemolysate for blood firmed whenever a relevant analytical variable in the
direct glucose measurement is changed, e. g. the type
of haemolysing agent, reagent composition, duration
~ , . Ar_ , , Γ and/or temperature o f incubation. Here a n e w exper-M Enzymes: Hexokinase, ATP: Z)-hexose 6-phosphotransfer- , , · , ·, , ^ Λ
se, EC 2.7.1.1; Glucose-6-phosphate dehydrogenase, D-G\u- mental approach is described for such comparison
cose-6-phosphate: NADP oxidoreductase, EC 1.1.1.49; studies, in which haemolysate samples and the cor-
Phosphogluconate dehydrogenase 6-Phospho-^glucon- responding protein-free ultrafiltrates are analysed in
ate: NAD(P) 3-oxidoreductase (decarboxylatmg), EC A i. · r» · r ι · · · ι
1.1.1.44; Glucosephosphate isomerase, Z)-Glucose-6-phos- the same run- A bnef presentation of this principle
phate ketol-isomerase, EC 5.3.1.9. has already appeared as an abstract (6).
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Methods
Reagents and solutions
The reagent kit for glucose determination ("Glucoquant", cat-
alog No. 263826), haemolysing agent ("Hemolyzing Reagent",
catalog No. 262836), calibrator solution ("Precimat Glucose",
catalog No. 125555) and control serum ("Precinorm U", catalog
No. 171743 and "Precipath U", catalog No. 171778) were
purchased from Boehringer Mannheim, Mannheim, Germany.
They were used according to the instructions given by the
manufacturer.
Blood samples
Venous blood samples treated with sodium fluoride and EDTA
(final concentrations 50 and 3 mmol/1, respectively) were used
throughout the study. For the comparison studies 37 blood
samples were selected from the workload of the laboratory
according to their glucose concentration to cover the range of
3 to 15 mmol/1.
Sample preparat ion
Plasma was obtained by centrifuging blood samples at 1500 g
(10 minutes, room temperature).
Glucose-free matrix material was prepared by gel chromato-
graphy of each 2ml of pooled plasma samples on several
Sephadex G-25 M minicolumns (Column PD-10; Pharmacia,
Uppsala, Sweden) using 0.15 mol/1 NaCl solution as eluent.
The fractions obtained after addition of 2 ml eluent were pooled
and concentrated by ultrafiltration at 1800g. The concentra-
tions of total protein and glucose were ~ 55 g/1 (biuret method)
and < 0.01 mmol/1, respectively. For the recovery and distri-
bution experiments this matrix material was spiked with 167
mmol/1 Z>-glucose (catalog No. 8337, E. Merck, Darmstadt,
Germany) solution to obtain a final concentration of 16.7
mmol/1.
Before direct analysis or ultrafiltration the spiked matrix ma-
terial sample was diluted by mixing 1 part with 20 parts of the
haemolysing agent containing 50 mg/1 digitonin and 100 mg/1
maleinimide. Individual blood or plasma samples, calibrator
solution and control sera were diluted in the same manner.
adaptation of the hexokinase method, which has been used by
us for several years for routine measurement, while the 37 °C
procedure corresponds to the working scheme given by the
reagent manufacturer (ref. No. 1281-6357-1439) with the ex-
ception of slightly lower final dilution of the sample (1 : 546
instead of 1 : 561).
The ΔΑ for the calibrator solution and the unknowns were
obtained as the mean of quadruplicate determinations. Glucose
concentrations were calculated using spreadsheet software
(PlanPerfect Version 5.1, WordPerfect Corporation Orem,
Utah, U. S. A.). The between-run CV of single measurements
was 1.5 and 1.7% at 25 °C or 1.4 and 2.2% at 37 °C with
commercial control sera containing glucose concentrations of
6.3 and 13.1 mmol/1, respectively. The mean values determined
by us deviated by —3.0 and —2.0% from the assigned reference
method values.
Results
Distribution of glucose during ul t raf i l t ra t ion
The distribution of glucose during ultrafiltration was
checked in preliminary investigations. In seven exper-
iments the average recovery of glucose added to glu-
cose-free matrix material (see "Methods") was 100.3
(range: 97.7-102.5) %. After 1 :21 dilution and ul-
trafiltration of this material at 350 g the mean ratio
Of gluCOSe Concentrations: CdUutedsample/Cultrafiltered sample
was 1.004 (range: 0.998-1.017). The glucose concen-
tration in the ultrafiltrate is therefore in close agree-
ment with that of the diluted sample subjected to
ultrafiltration.
Stability of indicated absorbance change
Figure 1 shows the average glucose concentrations
(n = 37) measured at various time points after the
Ultrafi l t rat ion
For ultrafiltration, 2 ml of the protein-containing solution were
placed on the bottom of a Centrisart I (Cat. No. 12349-E,
Sartorius GmbH, G ttingen, Germany) centrifuge tube. After
inserting the disposable filtrate collector carrying the semi-
permeable membrane (cellulose triacetate; cutoff Mr about
20000) the tube was centrifuged in a swing head rotor for 40
minutes (350 g, room temperature), resulting in approx. 1 ml
colourless ultrafiltrate.
Measurement of glucose concentration
Glucose concentrations were measured spectrophotometrically
using an Abbott VP Series II Bichromatic Analyser (Abbott
Laboratories, Irving, TX, USA). Briefly, 10 μΐ blank solution
(H2O), dilutions of calibrator solution, control sera or unknown
samples (plasma or haemolysate and the corresponding ultra-
filtrates) were pipetted together with 250 μΐ reagent mixture
into a partition of the multicuvette. Four seconds later the first
absorbance reading at 340/380 nm (Ai) was taken and the
difference ΔΑ between the actual A2 reading and the first
revolution reading was printed at 124 s. The stability of the ΔΑ
readings was monitored until minute 14. The incubation tem-
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Fig. 1. Influence of incubation temperature and time on the
averages of measured glucose concentrations (n = 37):
haemolysate at 25 °C (D-D) and 37 °C (* *);
ultrafiltrate at 25 °C (O—O) and 37 °C (D o).
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Tab. 1. Regression analysis according to Passing & Bablok (7): Glucose concentrations measured without deproteinization in
haemolysate or diluted plasma (y) versus results obtained from corresponding ultrafiltrates (x). 4 min incubation time;
n = 37
Incubation temperature
Haemolysate versus ultrafiltrate Diluted plasma versus ultrafiltrate

































start of the reaction using either ultrafiltered or orig-
inal haemolysate. It can be seen that the relation
between the signals (ΔΑ340/38ο nm) of ultrafiltered sam-
ples and calibrator solution is rather constant for both
25 °C and 37 °C incubation. In the presence of orig-
inal haemolysate the mean value remains virtually
constant at 25 °C, while at 37 °C there is a striking
decay of ΔΑ with time.
Influence of the sample matrix on the preci-
sion of measurement
The within-run CV calculated from each of 26 meas-
urements of a haemolysate containing 3.7 mmol/1
glucose were 1.1 and 1.0% for incubation tempera-
tures of 25 °C and 37 °C, respectively, while the CV
with the corresponding ultrafiltrate was 1.2% (25 °C).
Comparison of glucose concentrations ob-
tained in the analysis of haemolysate or ul-
t raf i l t ra te
With 37 samples covering the concentration range
between 3 and 16 mmol/1 the glucose concentration
was determined in haemolysate and ultrafiltered hae-
ιαβ
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Fig. 3. Comparison of glucose concentrations measured in hae-
molysate and ultrafiltrate at 37 °C.
The difference chaemoiysate - cullrafiltrate is plotted against
^ultrafiltrate·
molysate, using both the 25 °C and the 37 °C proce-
dure (see "Methods"). Analogously diluted plasma
was analysed directly or after deproteinization by
ultrafiltration. The results of the regression analysis
of the paired data according to 1. c. (7) are shown in
table 1. The individual differences between measured
glucose concentrations in haemolysate and ultrafil-
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Fig. 2. Comparison of glucose concentrations measured in hae-
molysate and ultrafiltrate at 25 °C.
The difference chaemoiysate - Cuhnfmnte is plotted against
^ultrafiltrate·
Discussion
Ultrafi l t rat ion for deproteinization of sam-
ples
The 1 : 21 dilution of blood or plasma with a corre-
sponding decrease of the protein concentration re-
sulted in a much higher filtration rate, compared with
the ultrafiltration of undiluted serum or plasma, as
used for the measurement of creatinine (8) or am-
monia (9). After 1 : 21 dilution of the blood or plasma
proteins their volume displacement effect is negligible,
and an 1 :1 distribution of glucose during ultrafiltra-
tion can be anticipated. This was verified by experi-
ments using matrix material with a known concentra-
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 30,1992 / No. 6
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tion of added glucose (see "Results"). Interestingly a
slight underrepresentation of glucose in the ultrafil-
trate in the order of 2 — 3% was observed in distri-
bution experiments, if the filtration rate was further
increased by centrifuging the ultrafilter at 1700 instead
of 350 g (data not shown).
The advantage of ultrafiltration with respect to con-
ventional deproteinization with protein precipitating
agents is that a dilution and contamination of the
sample is avoided (6). This assures compatibility of
the sample with the analytical system used; differences
between results from direct analysis and from ultra-
filtrate analysis, which exceed the random variation,
can be attributed to non-specificity or interference
caused by the high-molecular-mass components.
Use of ultrafi l trates for comparison studies
Two variants of an automated procedure for direct
measurement of glucose concentration in haemolysate
or plasma, differing only with respect to the temper-
ature chosen for incubation (25 or 37 °C), were in-
vestigated. The comparison experiments using ultra-
filtrates for reference show that at 25 °C there is good
agreement between results, while at 37 °C measured
values deviate systematically by —0.43 mmol/1 (see
tab. 1 and fig. 2 and 3). The cause of this negative
deviation of results observed at 37 °C in the presence
of haemolysate has not been identified; its extent is
time dependent (see fig. 1). With an alternative hexo-
kinase reagent of different composition inconstant
absorbance in direct haemolysate analysis was not
observed (10).
The allowable systematic deviation in the measure-
ment of blood glucose derived from accepted guide-
lines for statistical quality control (11,12) is 5%, e. g.,
0.25 mmol/1 if the expected value is 5 mmol/1. The
use of 37 °C for glucose determination in haemoly-
sates with the investigated analytical system would
therefore require correction of the results by a con-
stant value. Better still, this incubation temperature
should be avoided, because the measurement of glu-
cose should be free of bias (13).
As can be seen from the data in table 1, the agreement
of results obtained with diluted plasma and the cor-
responding ultrafiltrates is also better at 25 than at
37 °C. However, the offset and slope obtained in
regression analysis did not differ significantly in the
37 °C procedure from 0 or 1, respectively.
The present study shows that direct analysis of hae-
molysate using an incubation temperature of 25 °C
gives a good analytical performance, which is equiv-
alent to a more laborious variant of the method
involving deproteinization. This confirms earlier re-
ports on the use of manual (5) or mechanised tech-
niques (14) at room temperature. On the other hand
it should be emphasized that variants of the haemo-
lysate procedure (e.g., with incubation at 37 °C)
should be carefully evaluated before they are imple-
mented for clinical service.
Since a suitable stable reference material for quality
control is lacking, comparison studies are essential.
The use of ultrafiltered samples for reference as de-
scribed in this paper appears to be a valuable tool in
such studies.
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